DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
A Single Centre Review of Bortezomib Home-Administration in Myeloma Patients: Portsmouth Experience
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Next-generation multiple myeloma treatment: a pharmacoeconomic perspective - ScienceDirect
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
Approved for use in:
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials | Scientific Reports
VAD and similar alternate regimens | Download Table
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Frontiers | Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis
Doxil, Vincritine, Reduced Frequency Dexamethasone in Combination with Thalidomide (DVd-T) Is Associated with Higher Overall and Progression Free Survival as Compared to DVd in Patients with Multiple Myeloma (MM). - ScienceDirect
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Daratumumab With Standard Regimen Improves PFS, ORR Independent of Cytogenetic Risk in Multiple Myeloma
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
SYNOPSIS
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis - ScienceDirect
Hemato | Free Full-Text | Why Immunotherapy Fails in Multiple Myeloma
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Hull University Teaching Hospitals and North Lincolnshire NHS Trusts Haematology Multidisciplinary Team Guideline and Pathway Mu
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
